STERIS plc $STE Stake Trimmed by McCollum Christoferson Group LLC

Posted by George Bondi on Oct 13th, 2026

McCollum Christoferson Group LLC lessened its holdings in STERIS plc (NYSE:STE – Free Report) by 7.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 30,138 shares of the medical equipment provider’s stock after selling 2,535 shares during the quarter. STERIS accounts for approximately 0.9% of McCollum Christoferson Group LLC’s investment portfolio, making the stock its 24th biggest position. McCollum Christoferson Group LLC’s holdings in STERIS were worth $6,329,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Wellington Management Group LLP boosted its stake in STERIS by 21.9% in the second quarter. Wellington Management Group LLP now owns 3,502,897 shares of the medical equipment provider’s stock valued at $737,605,000 after buying an additional 629,532 shares in the last quarter. Janus Henderson Group PLC raised its stake in STERIS by 25.7% during the first quarter. Janus Henderson Group PLC now owns 1,863,139 shares of the medical equipment provider’s stock worth $411,995,000 after acquiring an additional 380,504 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in STERIS by 4.3% during the first quarter. Dimensional Fund Advisors LP now owns 1,113,845 shares of the medical equipment provider’s stock worth $246,295,000 after acquiring an additional 46,391 shares in the last quarter. Bessemer Group Inc. raised its stake in STERIS by 8.8% during the first quarter. Bessemer Group Inc. now owns 1,048,636 shares of the medical equipment provider’s stock worth $231,883,000 after acquiring an additional 85,188 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in shares of STERIS by 1.0% in the first quarter. Principal Financial Group Inc. now owns 890,562 shares of the medical equipment provider’s stock worth $196,931,000 after acquiring an additional 9,226 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Piper Sandler reaffirmed an “overweight” rating and set a $275.00 price target (up from $270.00) on shares of STERIS in a report on Friday, August 7th. Weiss Ratings reissued a “hold (c)” rating on shares of STERIS in a research note on Monday, August 24th. UBS Group cut their target price on shares of STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research report on Friday, August 7th. Finally, Wall Street Zen cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $271.33.

Check Out Our Latest Analysis on STERIS

Insider Transactions at STERIS

In other STERIS news, Director Mohsen Sohi sold 4,058 shares of the company’s stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $235.78, for a total value of $956,795.24. Following the completion of the transaction, the director directly owned 24,305 shares in the company, valued at approximately $5,730,632.90. This represents a 14.31% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.12% of the company’s stock.

STERIS Trading Down 0.6%

STERIS stock traded down $1.26 during trading hours on Tuesday, hitting $217.72. The stock had a trading volume of 183,105 shares, compared to its average volume of 763,620. The business’s 50 day simple moving average is $222.15 and its 200-day simple moving average is $217.93. STERIS plc has a one year low of $195.14 and a one year high of $269.44. The stock has a market cap of $21.23 billion, a price-to-earnings ratio of 26.62 and a beta of 0.92. The company has a quick ratio of 1.35, a current ratio of 1.91 and a debt-to-equity ratio of 0.23.

STERIS (NYSE:STE – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.49 by $0.10. The company had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.49 billion. STERIS had a return on equity of 14.34% and a net margin of 13.34%. The business’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the business posted $2.34 earnings per share. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. On average, equities analysts predict that STERIS plc will post 11.12 EPS for the current fiscal year.

STERIS Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Shareholders of record on Friday, September 4th were issued a dividend of $0.69 per share. This represents a $2.76 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend was Friday, September 4th. This is a positive change from STERIS’s previous quarterly dividend of $0.63. STERIS’s payout ratio is presently 33.74%.

About STERIS

(Free Report)

STERIS plc (NYSE: STE) provides products and services designed to support infection prevention, surgical procedures, and the manufacture of healthcare and pharmaceutical products. The company serves healthcare providers, pharmaceutical and biotechnology manufacturers, and other organizations that require controlled, sterile environments.

Its Healthcare segment offers sterilization and decontamination equipment, operating-room products, surgical instruments, endoscopy products, consumables, and related maintenance and procedural services.